Toxicology
Screening for Forensically Relevant Drugs Using Data-Independent High-Resolution Mass Spectrometry
Screening for Forensically Relevant Drugs Using Data-Independent High-Resolution Mass Spectrometry
Development of a Comprehensive Workflow for Postmortem Insulin Testing in Cases of Suspected Insulin Homicide
Validation of a LC-DAD-ESI/MS/MS Method for the Accurate Measurement of Δ9-THC and Δ9-THCA-A Among Twenty Cannabinoids in Various Products of Cannabis
White Paper – Information Sharing Between Medicolegal Death Investigators And Toxicology Testing Services
What’s Known and Unknown About Marijuana (Part Two)
Development of Portable Surface-Enhanced Raman Spectroscopy Nanosensors for Ultrasensitive Characterization of Drugs in Human Biofluids
Expanded Quantitative Cannabinoid Testing in Biological Specimens to Combat the Ever Changing Cannabis Landscape
Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
Aptamer-Based Fentanyl Detection in Biological Fluids
Transitioning surface-enhanced Raman spectroscopy (SERS) into the forensic drug chemistry and toxicology laboratory: Current and future perspectives
Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
High Resolution Mass Spectrometry Drug Screening in Forensic Toxicology: A Cost Benefit Analysis
Stability of Synthetic Cathinones in Urine
What's Known and Unknown About Marijuana, Part 2
Marijuana legalization poses many challenges — especially those related to drug chemistry and toxicology — for researchers, law enforcement, and policy makers. In the latest episode of Justice Today, NIJ Communications Assistant Josh Mondoro hosts a conversation with NIJ Scientist Frances Scott about marijuana toxicology, including comparing its effects to alcohol, measuring impairment, and maintaining public safety as more and more states legalize recreational marijuana.